A coalition of advocacy groups and lawmakers urged the Federal Trade Commission to hold companies accountable as online harms against people of color and women proliferate.
What was going on in the Supreme Court’s opinion in West Virginia v. EPA? Everyone has a sense the new “major questions doctrine” will create problems for the antitrust agencies. But what kinds of problems exactly?
Current Issue: 922
The following article first appeared on July 27 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com.
D. Bruce Hoffman brings vast experience challenging and defending mergers to his new job as acting director of the Federal Trade Commission’s Bureau of Competition.
Let’s call the last six months a mixed bag for Maureen Ohlhausen of the Federal Trade Commission.
When congressional Democratic leaders unveiled their economic agenda recently, it contained the usual crowd-pleasers: better education, lower prescription drug prices and tax incentives for...
It won’t rival the Federal Trade Commission’s largest-ever false advertising case, but nearly $4 billion could be at stake in a federal trial in Oakland, California, this month in which the FTC...
Last year, generic drugmakers filed 150 complaints with the Food and Drug Administration that branded drug manufacturers were misusing the agency’s regulations to block them from offering cheaper...